Who
-
Adults in South Korea (≥19 years) enrolled in the National Health Insurance Service (NHIS) screening program.
-
408,873 people with predialysis CKD (stages 1–5 not on dialysis), each matched 1:1 to 408,873 controls without CKD by age, sex, smoking history, and low-income status (total ≈ 817,746 participants).
What
-
Focus: To assess whether predialysis CKD (not yet on dialysis or transplanted) is associated with higher risk of incident active tuberculosis (TB), and to examine short-term mortality after TB.
-
Main findings:
-
Incidence of active TB was higher in predialysis CKD vs matched controls:
-
CKD: 1704 TB cases; 137.5 per 100,000 person-years
-
Controls: 1518 TB cases; 121.9 per 100,000 person-years
-
Adjusted hazard ratio (HR) for active TB with CKD: 1.21 (95% CI 1.13–1.30).
-
-
By CKD stage (vs controls, fully adjusted):
-
Stage 1 (eGFR ≥90 + albuminuria): HR ≈ 1.82
-
Stage 2 (eGFR 60–89 + albuminuria): HR ≈ 1.19 (borderline)
-
Stage 3 (eGFR 30–59): HR ≈ 1.16
-
Stage 4/5 without dialysis (eGFR <30): HR ≈ 1.85.
-
-
CKD was associated with higher risks of pulmonary, non-pulmonary, and miliary TB.
-
Among those who developed TB, 1-year all-cause mortality was higher in the CKD group (adjusted HR 1.68; 95% CI 1.28–2.22).
-
-
Authors’ conclusion: Predialysis CKD is associated with increased incidence of active TB and worse short-term prognosis after TB. Particular concern is warranted for CKD stage 1 and advanced CKD (stages 4/5) not on dialysis.
When
-
Health screenings to define CKD status: 2012–2016.
-
Follow-up for TB events and mortality: from each participant’s index examination date until TB, death, or December 31, 2016.
-
Median follow-up: about 3.0 years in both CKD and control groups.
Where
-
Republic of Korea, using the nationwide National Health Insurance Database (NHID) and its general health screening program.
Why
-
CKD prevalence is increasing globally and in countries where TB remains endemic.
-
Dialysis and kidney transplantation are known TB risk factors, but large-scale data on TB risk in predialysis CKD were lacking.
-
Because CKD is associated with immune dysfunction and infection risk, the authors aimed to clarify if earlier CKD stages already confer significantly increased TB risk to guide surveillance and management.
How
-
Design: Nationwide retrospective population-based cohort study.
-
Data source: Korean NHID, including:
-
General health screening data (serum creatinine, urine dipstick albuminuria, BMI, smoking, etc.).
-
Claims data with mandatory TB insurance codes and ICD-10 diagnoses to identify active TB (A15–A19).
-
-
Population definition:
-
Included adults with ≥2 health screenings (2012–2016) using Jaffe-based creatinine.
-
Predialysis CKD: persistent CKD indicators (eGFR <60 mL/min/1.73 m² and/or dipstick albuminuria ≥1+) in two or more consecutive screenings.
-
Excluded those with prior TB, prior kidney replacement therapy, fluctuating/transient CKD labs, or (for controls) any CKD codes.
-
-
Exposure: Presence and stage of predialysis CKD, categorized per KDIGO into stages 1, 2, 3, and 4/5 (non-dialysis) using baseline eGFR and albuminuria.
-
Outcome measures:
-
Primary: Incident active TB (pulmonary, non-pulmonary, miliary) during follow-up.
-
Secondary: TB-associated mortality, defined as 1-year all-cause death after TB diagnosis.
-
-
Analysis:
-
1:1 matching of CKD patients to controls by age, sex, smoking history, and low-income status.
-
Incidence rates calculated per 100,000 person-years.
-
Cox proportional hazards models with:
-
Model 1: adjusted for matching factors.
-
Model 2: additionally adjusted for BMI, residence (urban/rural), diabetes, hypertension, cancer, COPD, immunosuppressant use.
-
-
Subgroup analyses by CKD stage and TB site; risk factor analysis for TB within the CKD cohort using multivariable Cox with backward elimination.
No comments:
Post a Comment